Vidipha Central Pharmaceutical JSC (HOSE:VDP)
Vietnam · Delayed Price · Currency is VND 60,500
0.00 (0.00%)
At close: Apr 7, 2026
HOSE:VDP Revenue
In the year 2025, Vidipha Central Pharmaceutical JSC had annual revenue of 985.64B VND with 5.47% growth. Vidipha Central Pharmaceutical JSC had revenue of 275.11B in the quarter ending December 31, 2025, with 8.41% growth.
Revenue
985.64B
Revenue Growth
+5.47%
P/S Ratio
1.32
Revenue / Employee
5.05B
Employees
195
Market Cap
1.30T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 985.64B | 51.15B | 5.47% |
| Jan 1, 2025 | 934.49B | -84.83B | -8.32% |
| Dec 31, 2023 | 1.02T | 11.52B | 1.14% |
| Jan 1, 2023 | 1.01T | 800.84B | 386.97% |
| Dec 31, 2008 | 206.95B | 15.51B | 8.10% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Traphaco JSC | 2.66T |
| Ha Tay Pharmaceutical JSC | 2.40T |
| Domesco Medical Import - Export Joint-Stock | 2.07T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| OPC Pharmaceutical JSC | 1.12T |
| Ben Tre Pharmaceutical JSC | 860.31B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |